Pediatric Diabetology Unit, Pediatric Department, S. Chiara General Hospital, Largo Medaglie d'Oro, 9, 38122, Trento, Italy.
Health Management, General Hospital of Bolzano, Bolzano, Italy.
Acta Diabetol. 2022 Jul;59(7):911-919. doi: 10.1007/s00592-022-01882-3. Epub 2022 Apr 9.
Data about sleep quality and quantity are not available in patients with type 1 diabetes (T1D) using intermittently scanned continuous glucose monitoring (isCGM). We questioned whether the isCGM with alarms could fragment sleep in patients and parents, compared to isCGM without alarms.
A prospective, observational study including 47 child-adolescents with T1D who had experience with isCGM without alarms (Freestyle Libre 1-FSL1). They were asked to wear the isCGM with alarms (Freestyle Libre 2-FSL2) for 14 days. Patients enrolled and their caregiver (s), during a 14 day period with FSL1 and the following 14 days with FSL2, completed psychosocial and sleep-related questionnaires. Furthermore they wore an actigraph that was downloaded to a web platform and processed by the validated and certified algorithm "Dormi."
By the switch to the alarmed FSL2 we found about a 5% increase in Time In Range (from 62.5 to 67.8%), a reduction in time spent in hypoglycemia, number of weekly hypoglycemic events, and coefficient of variation. We did not find significant differences in sleep parameters in patients and their parents; therefore, alarms did not worsen the duration and quality of sleep. A significant improvement in the Quality of Life was perceived by parents using FSL2.
Introduction of alarms in isCGM systems gives, in the short term, an improvement in metabolic control in terms of time in range and reduction in hypoglycemia, without worsening duration and quality of sleep, measured by actigraphy, in children-adolescent and their parents.
使用间歇性扫描连续血糖监测(isCGM)的 1 型糖尿病(T1D)患者缺乏睡眠质量和数量的数据。我们质疑与没有报警功能的 isCGM 相比,具有报警功能的 isCGM 是否会使患者和家长的睡眠碎片化。
这是一项前瞻性、观察性研究,纳入了 47 名有过无报警功能 isCGM(Freestyle Libre 1-FSL1)使用经验的儿童和青少年 T1D 患者。他们被要求佩戴带报警功能的 isCGM(Freestyle Libre 2-FSL2)14 天。患者及其照顾者(s)在佩戴 FSL1 的 14 天期间和接下来的 14 天佩戴 FSL2 期间,完成了社会心理和睡眠相关的问卷调查。此外,他们还佩戴了一个活动记录仪,该记录仪被下载到一个网络平台上,并由经过验证和认证的算法“Dormi”进行处理。
通过切换到带报警功能的 FSL2,我们发现患者的时间在目标范围内(从 62.5%增加到 67.8%)、低血糖时间、每周低血糖事件次数和变异系数都有大约 5%的增加。我们没有发现患者和他们的父母的睡眠参数有显著差异;因此,报警功能并没有恶化他们的睡眠持续时间和质量。使用 FSL2,父母认为生活质量有显著改善。
在短期内,在带报警功能的 isCGM 系统中引入报警功能可改善血糖控制,提高时间在目标范围内的比例,减少低血糖,同时不会通过活动记录仪测量到的睡眠持续时间和质量恶化,这在儿童和青少年及其父母中都得到了体现。